MSH6 and endometrial carcinoma: Among 543 endometrial carcinoma samples detected by Hampel et al., MSH6 mutations were the most common (0.92%, 5/543), followed by MSH2 mutations (0.37%, 2/543) and MLH1 mutations (0.18%, 1/543)7.